ABVC BioPharma, Inc. Adjustments to Additional Paid in Capital, Other
ABVC BioPharma, Inc. (ABVC) reported Adjustments to Additional Paid in Capital, Other of $7.67 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-04-30.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2025-04-30
- ABVC BioPharma, Inc. adjustments to additional paid in capital, other for the quarter ending 2025-03-31 was $7.67M.
- ABVC BioPharma, Inc. adjustments to additional paid in capital, other for fiscal 2014 was $54.59K.
- ABVC BioPharma, Inc. adjustments to additional paid in capital, other for fiscal 2012 was $0.00.
- ABVC BioPharma, Inc. adjustments to additional paid in capital, other for fiscal 2011 was $0.00.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|---|
| 2025-03-31 | $7.67M 10-Q · filed 2025-04-30 | |
| 2014-09-18 | $54.59K 10-K · filed 2015-04-17 | |
| 2012-09-30 | $0.00 10-K · filed 2015-04-16 | |
| 2011-09-30 | $0.00 10-K · filed 2015-04-15 |